PepGen (PEPG) EBT (2021 - 2026)

PepGen has reported EBT for 6 years, with the latest figure at -$17.7 million in Q1 2026.

• Quarterly EBT rose 41.24% year-over-year to -$17.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$77.2 million (up 24.93% YoY) and the FY2025 annual result came in at -$89.6 million, up 1.09% from the prior year.
• EBT grew to -$17.7 million in Q1 2026 per PEPG's latest filing, from -$18.3 million in the prior quarter.
• Over five years, EBT peaked at -$13.8 million in Q1 2022 and troughed at -$47.0 million in Q4 2022.
• A 5-year average of -$22.0 million and a median of -$19.4 million in 2023 frame the typical range for EBT.
• The sharpest annual moves came in 2022 and 2023: EBT plunged 4784.01% in 2022, then jumped 58.71% in 2023.
• Over 5 years, EBT stood at -$47.0 million in 2022, then surged by 58.71% to -$19.4 million in 2023, then decreased by 17.7% to -$22.9 million in 2024, then grew by 19.98% to -$18.3 million in 2025, then climbed by 2.97% to -$17.7 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$17.7 million, -$18.3 million, and -$18.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.